...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >RTI 113, a 3-phenyltropane analog, produces long-lasting cocaine-like discriminative stimulus effects in rats and squirrel monkeys.
【24h】

RTI 113, a 3-phenyltropane analog, produces long-lasting cocaine-like discriminative stimulus effects in rats and squirrel monkeys.

机译:RTI 113是一种3-苯基环戊烷类似物,在大鼠和松鼠猴中产生长效的可卡因样歧视性刺激作用。

获取原文
获取原文并翻译 | 示例

摘要

The 3-phenyltropane analog, 3beta-(4-chlorophenyl)tropane-2beta-carboxylic acid phenyl ester hydrochloride (RTI 113), has been shown to decrease cocaine self-administration in rats, squirrel monkeys and rhesus monkeys. Consequently, it has been proposed as a potential agonist pharmacotherapy for cocaine dependence. However, the time course of the discriminative stimulus effects of RTI 113 has not been determined. The present study was designed to compare the time course of the discriminative stimulus effects of RTI 113 with that of cocaine in rats and squirrel monkeys. Tests were conducted using a drug discrimination procedure in which rats and squirrel monkeys were trained to discriminate 10 and 0.3 mg/kg cocaine from saline, respectively. RTI 113 substituted for cocaine in both species. The time course of the discriminative stimulus effects of RTI 113 was approximately five times longer compared to that of cocaine. RTI 113 is a 3-phenyltropane analog that has long acting cocaine-like discriminative stimulus effects in both rats and squirrel monkeys. These results, combined with those indicating that RTI 113 decreases cocaine self-administration, suggest that RTI 113, or analogs of RTI 113, may be useful tools for developing potential agonist therapies for cocaine dependence.
机译:3-苯基环烷类似物3beta-(4-氯苯基)tropane-2beta-羧酸苯基酯盐酸盐(RTI 113)已显示可减少可卡因在大鼠,松鼠猴和恒河猴中的自我给药。因此,已提出可卡因依赖性的潜在激动剂药物疗法。但是,尚未确定RTI 113的歧视性刺激效果的时程。本研究旨在比较RTI 113和可卡因对大鼠和松鼠的歧视性刺激作用的时程。使用药物鉴别程序进行测试,其中训练了大鼠和松鼠猴以分别从盐水中鉴别出10和0.3 mg / kg可卡因。 RTI 113替代了两种物种中的可卡因。与可卡因相比,RTI 113的歧视性刺激作用的时程大约长五倍。 RTI 113是一种3-苯基环戊烷类似物,在大鼠和松鼠猴中均具有长效可卡因样的歧视性刺激作用。这些结果,与表明RTI 113降低可卡因自我给药的结果相结合,表明RTI 113或RTI 113的类似物可能是开发潜在的可卡因依赖性激动剂疗法的有用工具。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号